<DOC>
	<DOCNO>NCT01377077</DOCNO>
	<brief_summary>Rationale : Punch graft safe , simple widely use technique vitiligo . However , reliable data available effect punch depth punch size . Objectives : Primary : compare efficacy safety different punchdepths punchsizes punch graft patient segmental non-segmental vitiligo . Secondary : assess practical aspect patient preference different punch graft technique . Study design : Prospective observer blind randomise control study . Study population : 35 patient â‰¥ 18 year segmental stable non-segmental vitiligo receive regular treatment punch graft Netherlands Institute Pigment Disorders ( SNIP ) Academic Medical Centre University Amsterdam . Methods : Four depigmented region trunk upper extremity randomly allocate either epidermal 1,5 mm punch grafting , epidermal 1mm punch grafting , dermal 1,5 mm punch graft dermal 1 mm punch graft . After graft , region receive UV-therapy twice week 3 month . Three six month graft , repigmentation lesion assess measure outgrowth . Main study parameter/endpoint : Outgrowth pigment six month . Nature extent burden risk associate participation , benefit group relatedness : The study involve 16 additional punch graft additional visit institute . Patients miss regular treatment . The extra time due participation study 40 minute . No increase risk side effect expect place 16 additional punch graft . 1 .</brief_summary>
	<brief_title>Punchgrafting Techniques Vitiligo</brief_title>
	<detailed_description />
	<mesh_term>Vitiligo</mesh_term>
	<mesh_term>Piebaldism</mesh_term>
	<criteria>Patients nonsegmental segmental vitiligo medical treatment Netherlands Institute Pigment Disorders Age 18 60 year Patient willing able give write informed consent Vitiligo stable since 12 month without systemic therapy 6 month without topical therapy define absence new lesion and/or enlargement exist lesion . Vitiligo lesion extremities trunk large 5x5cm UV therapy systemic immunosuppressive treatment last 12 month Local treatment vitiligo last 6 month Vitiligo lesion folliculair nonfolliculair repigmentations Skin type 1 Hypertrophic scar Keloid Cardial insufficiency Patients history hypersensitivity ( UVB ) light allergy local anesthesia . Patients pregnant breastfeed Patients competent understand procedure involve Patients personal history melanoma nonmelanoma skin cancer Patients first degree relative melanoma skin cancer Patients atypical nevus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>vitiligo</keyword>
	<keyword>piebaldism</keyword>
	<keyword>punchgrafting</keyword>
	<keyword>minigrafting</keyword>
	<keyword>stable least 12 month</keyword>
</DOC>